Lessee, Operating Lease, Liability, to be Paid, Year Two in USD of Singular Genomics Systems, Inc. from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Singular Genomics Systems, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and change rate from Q2 2021 to Q3 2024.
  • Singular Genomics Systems, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 30 Sep 2024 was $4.81M, a 15.9% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

Singular Genomics Systems, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.81M -$911K -15.9% 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $5.72M +$156K +2.81% 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 $5.72M +$156K +2.81% 31 Mar 2024 10-Q 14 May 2024
Q4 2023 $5.72M -$2.05M -26.4% 31 Dec 2023 10-K 18 Mar 2024
Q3 2023 $5.72M -$2.05M -26.4% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $5.56M -$2.35M -29.7% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $5.56M +$4.23M +319% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $7.77M +$873K +12.7% 31 Dec 2022 10-K 02 Mar 2023
Q3 2022 $7.76M -$130K -1.65% 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 $7.91M +$17K +0.22% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $1.33M 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $6.89M 31 Dec 2021 10-K 14 Mar 2022
Q3 2021 $7.89M 30 Sep 2021 10-Q 09 Nov 2021
Q2 2021 $7.89M 30 Jun 2021 10-Q 03 Aug 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.